Hande Turna

Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial

Achim Rittmeyer, Fabrice Barlési, Daniel Waterkamp et al. · The Lancet · 2016 · 4.7K citations · Full text

Non-small-cell Lung Cancer, Medicine, Metronomic Therapy +12

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony Mok, Yi‐Long Wu, Iveta Kudaba et al. · The Lancet · 2019 · 3.2K citations · Full text

Extraskeletal Ewing's Sarcoma Family of Tumors in Adults: Prognostic Factors and Clinical Outcome

Deniz Tural, Nil Molinas Mandel, Sergülen Dervişoğlu et al. · Japanese Journal of Clinical Oncology · 2012 · 70 citations

Reactivation of Hepatitis B Virus Infection with Cytotoxic Therapy in Non-Hodgkin's Lymphoma

Mustafa Özgüroğlu, Hande Turna, Süheyla Serdengeçti · Medical Oncology · 2004 · 44 citations

Lymphoid Neoplasia, Cytotoxic Therapy, Hepatology +9

A case–control study of non-alcoholic fatty liver disease in breast cancer

Mustafa Özgüroğlu, İsmail Mihmanlı, Hande Turna et al. · Medical Oncology · 2007 · 44 citations

Metabolic Syndrome, Metabolic Associated Steatohepatitis, Hepatology +13